IVBT (Innovation1 Biotech) ROCE %: 0.00% (As of Feb. 2024)


IVBT Innovation1 Biotech Inc IVBT
12 GF Score
Price $0.00
View Full Analysis

What is Innovation1 Biotech ROCE %?

Innovation1 Biotech IVBT 12 ROCE % is 0.00% as of Feb. 2024. GuruFocus rates IVBT with a GF Score™ of 12/100.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Innovation1 Biotech's annualized ROCE % for the quarter that ended in Feb. 2024 was 0.00%.


Innovation1 Biotech  (OTCPK:IVBT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Innovation1 Biotech ROCE % Related Terms


Innovation1 Biotech ROCE % Historical Data

* Premium members only.

The historical data trend for Innovation1 Biotech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation1 Biotech ROCE % Chart

Innovation1 Biotech Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
ROCE %
Get a 7-Day Free Trial Premium Member Only -162.50 0.00 0.00 -586.99 -104.86

Innovation1 Biotech Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -117.95 -56.98 0.00 0.00 0.00
IVBT
12GF Score
Innovation1 Biotech Inc IVBT
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innovation1 Biotech ROCE % Calculation

Innovation1 Biotech's annualized ROCE % for the fiscal year that ended in Aug. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Aug. 2023 )  (A: Aug. 2022 )(A: Aug. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Aug. 2023 )  (A: Aug. 2022 )(A: Aug. 2023 )
=-5.736/( ( (43.963 - 29.812) + (0.076 - 3.287) )/ 2 )
=-5.736/( (14.151+-3.211)/ 2 )
=-5.736/5.47
=-104.86 %

Innovation1 Biotech's ROCE % of for the quarter that ended in Feb. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Feb. 2024 )  (Q: Nov. 2023 )(Q: Feb. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Feb. 2024 )  (Q: Nov. 2023 )(Q: Feb. 2024 )
=-0.6/( ( (0.02 - 2.656) + (0.122 - 2.904) )/ 2 )
=-0.6/( ( -2.636 + -2.782 )/ 2 )
=-0.6/-2.709
=0 %

(1) Note: The EBIT data used here is four times the quarterly (Feb. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
Innovation1 Biotech (IVBT) has a ROCE % of 0.00% as of Feb. 2024.
Is Innovation1 Biotech's ROCE % too high?
Innovation1 Biotech's current ROCE % is 0.00%. Overall, Innovation1 Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Innovation1 Biotech's ROCE % compare to NVIV and PXMD?
Innovation1 Biotech's ROCE % of 0.00% can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Diversified Financial Services company?
A good ROCE % depends on the Diversified Financial Services industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Innovation1 Biotech's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation1 Biotech stock overvalued right now?
Innovation1 Biotech (IVBT) has a current ROCE % of 0.00%. The current ROCE % is 0.00%. Innovation1 Biotech's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Innovation1 Biotech (IVBT), the current ROCE % is 0.00% as of Feb. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation1 Biotech Business Description

Address 7 Grand View Avenue, Somerville, MA, USA, 02143
Innovation1 Biotech Inc is a shell company.
12GF Score

Get the complete analysis for IVBT

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price